Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of recombinant Mycobacterium tuberculosis ESAT6-CFP10 allergen after BCG vaccination
CTR20160018Phase 3Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of C-Tb in Tuberculosis (TB), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Feb 2016; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20160018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160018.